Pramipexole NEW
| Price | $30 |
| Package | 500mg |
| Supply Ability: | 10g |
| Update Time: | 2026-05-26 |
Product Details
| Product Name: Pramipexole | CAS No.: 104632-26-0 |
| Purity: 99.65% | Supply Ability: 10g |
| Release date: 2026/05/26 |
Product Introduction
Bioactivity
| Name | Pramipexole |
| Description | Pramipexole (SND 919) is a selective dopamine receptor agonist used in the therapy of Parkinson disease. Pramipexole therapy is associated with a low rate of transient serum enzyme elevations during treatment but has not been implicated in cases of clinically apparent acute liver injury. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO : 75 mg/mL (354.9 mM), Sonication is recommended. H2O : 8.93 mg/mL (42.26 mM), Sonication is recommended. 10% DMSO+40% PEG300+5% Tween 80+45% Saline : 2 mg/mL (9.46 mM), Sonication is recommended. Ethanol : 39 mg/mL (184.55 mM), Sonication is recommended. |
| Keywords | transient | tMCAO | syndrome | SND-919 | SND919 | RLS | restless | recovery | Pramipexole | Parkinson's | occlusion | neuroprotection | neurological | middle | legs | Inhibitor | inhibit | DopamineReceptor | Dopamine Receptor | Dopamine | disease | D4 | D3 | D2L | cerebral | artery |
| Inhibitors Related | Trifluoperazine dihydrochloride | Clozapine N-Oxide | Mirtazapine | Hexamethonium Bromide | Butyrophenone | Octopamine hydrochloride | L-DOPA | Creatine | Dopamine hydrochloride | Oxolinic acid | Mianserin hydrochloride | Doxepin hydrochloride |
| Related Compound Libraries | Anti-Neurodegenerative Disease Compound Library | Bioactive Compound Library | Anti-Alzheimer's Disease Compound Library | Membrane Protein-targeted Compound Library | EMA Approved Drug Library | Drug Repurposing Compound Library | FDA-Approved Drug Library | Anti-Cancer Approved Drug Library | Immunology/Inflammation Compound Library | Bioactive Compounds Library Max | GPCR Compound Library | Anti-Cancer Drug Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
|
VIP1Y
|
Rongchuang International
|
2026-07-08 | ||
| $30.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-26 | |
| $9.90 |
Hebei Chuanghai Biotechnology Co., Ltd
|
2026-03-20 | ||
| $1.10 |
VIP6Y
|
Dideu Industries Group Limited
|
2025-11-18 | |
|
HangZhou RunYan Pharma Technology Co.,LTD.
|
2025-08-21 | |||
| $9.00 |
Wuhan Boyuan Import & Export Co., LTD
|
2024-01-08 | ||
| $400.00 |
Weijer International Trade (Hebei) Co., Ltd
|
2023-08-16 | ||
| $150.00 |
Henan Bao Enluo International TradeCo.，LTD
|
2023-05-27 | ||
| $10.00 |
Hebei Anda Technology Co., LTD
|
2022-09-27 | ||
| $126.00 |
Baoji Guokang Healthchem co.,ltd
|
2021-11-02 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY